These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11681514)

  • 1. Tamoxifen side effects, age-related macular degeneration (AMD) or cancer associated retinopathy (CAR)?
    Sadowski B; Kriegbaum C; Apfelstedt-Sylla E
    Eur J Ophthalmol; 2001; 11(3):309-12. PubMed ID: 11681514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral retinopathy and maculopathy in high-dose tamoxifen therapy.
    Bourla DH; Sarraf D; Schwartz SD
    Am J Ophthalmol; 2007 Jul; 144(1):126-8. PubMed ID: 17601434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen retinopathy: does it really exist?
    Lazzaroni F; Scorolli L; Pizzoleo CF; Savini G; De Nigris A; Giosa F; Meduri RA
    Graefes Arch Clin Exp Ophthalmol; 1998 Sep; 236(9):669-73. PubMed ID: 9782427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electrophysiological studies in breast carcinoma patients with tamoxifen retinopathy].
    Kuchenbecker J; Pump-Schmidt C; Olbricht S; Weise W; Behrens-Baumann W
    Ophthalmologe; 2001 Jan; 98(1):81-5. PubMed ID: 11220276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudocystic foveal cavitation in tamoxifen retinopathy.
    Doshi RR; Fortun JA; Kim BT; Dubovy SR; Rosenfeld PJ
    Am J Ophthalmol; 2014 Jun; 157(6):1291-1298.e3. PubMed ID: 24582991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ocular toxicity caused by tamoxifen: case report].
    Inada ET; Watanabe KP; Tanaka SG; Sakakisbara LA
    Arq Bras Oftalmol; 2005; 68(4):554-6. PubMed ID: 16322846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated retinopathy (CAR) with electronegative ERG: a case report.
    Goetgebuer G; Kestelyn-Stevens AM; De Laey JJ; Kestelyn P; Leroy BP
    Doc Ophthalmol; 2008 Jan; 116(1):49-55. PubMed ID: 17721792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tamoxifen retinopathy: a case series of clinical and functional data].
    Ritter C; Renner AB; Wachtlin J; Bechrakis NE; Krause L
    Ophthalmologe; 2008 Jun; 105(6):544-9. PubMed ID: 18415107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Unusual symptoms for tamoxifen-associated maculopathy].
    Hager T; Hoffmann S; Seitz B
    Ophthalmologe; 2010 Aug; 107(8):750-2. PubMed ID: 20393723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen maculopathy: The importance of screening and long follow-up.
    Zamorano Martín F; Rocha-de-Lossada C; Rachwani Anil R; Borroni D; Rodriguez Calvo de Mora M; España Contreras M
    J Fr Ophtalmol; 2020 Oct; 43(8):727-730. PubMed ID: 32620415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological and microperimetry changes in vitamin A deficiency retinopathy.
    Saker S; Morales M; Jhittay H; Wen Y; Amoaku W
    Doc Ophthalmol; 2015 Jun; 130(3):231-40. PubMed ID: 25626405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystalline deposits in the macula - tamoxifen maculopathy or macular telangiectasia?
    Rijal RK; Nakhwa C; Sindal MD
    Nepal J Ophthalmol; 2014; 6(2):227-9. PubMed ID: 25680254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab therapy for tamoxifen-induced crystalline retinopathy and severe cystoid macular edema.
    Rahimy E; Sarraf D
    Arch Ophthalmol; 2012 Jul; 130(7):931-2. PubMed ID: 22776935
    [No Abstract]   [Full Text] [Related]  

  • 14. Multifocal electroretinogram indicates visual field loss in acute zonal occult outer retinopathy.
    Arai M; Nao-i N; Sawada A; Hayashida T
    Am J Ophthalmol; 1998 Sep; 126(3):466-9. PubMed ID: 9744389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Adjuvant Tamoxifen Use on Macula Pigment Epithelium Optical Density, Visual Acuity and Retinal Thickness in Patients with Breast Cancer.
    Bicer T; Imamoglu GI; Caliskan S; Bicer BK; Gurdal C
    Curr Eye Res; 2020 May; 45(5):623-628. PubMed ID: 31684771
    [No Abstract]   [Full Text] [Related]  

  • 16. Tamoxifen-associated eye disease. A review.
    Nayfield SG; Gorin MB
    J Clin Oncol; 1996 Mar; 14(3):1018-26. PubMed ID: 8622006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectral Domain OCT Imaging Techniques in Tamoxifen Retinopathy.
    Neuville J; Yevseyenkov V
    Optom Vis Sci; 2015 Feb; 92(2):e55-9. PubMed ID: 25525894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular side-effects in breast cancer patients treated with tamoxifen and toremifene: a randomized follow-up study.
    Parkkari M; Paakkala AM; Salminen L; Holli K;
    Acta Ophthalmol Scand; 2003 Oct; 81(5):495-9. PubMed ID: 14510798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen retinopathy.
    Kaiser-Kupfer MI; Lippman ME
    Cancer Treat Rep; 1978 Mar; 62(3):315-20. PubMed ID: 647693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose tamoxifen retinopathy.
    Chang T; Gonder JR; Ventresca MR
    Can J Ophthalmol; 1992 Apr; 27(3):148-9. PubMed ID: 1586887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.